Barbault A.Amplitude‐modulated electromagnetic fields for the treatment of cancer: discovery of tumor‐specific frequencies and assessment of a novel therapeutic approach / A. Barbault, F.P. Costa, B. Bottger, R.F. Munden, F. Bomholt, N. Kuster, et al. // J. Exp. Clin. Cancer Res. – 2009. – Рр. 28-51. [PMC free article] [PubMed] [Google Scholar].

Evangelou A. Functionality of natural killer cells from end‐stage cancer patients exposed to resonant electromagnetic fields / A. Evangelou, I. Toliopoulos, C. Giotis, A. Metsios, I. Verginadis, Y. Simos et al. // Electromagn. Biol. Med. – 2011. – 30. – Рр. 46-56. [PubMed] [Google Scholar].

Haanen J.B.A.G. Managemen to ftoxicities fromimmuno therapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up / J.B.A.G. Haanen, F. Carbonnel, C. Robert, K.M. Kerr, S. Peters, J. Larkin // Ann.Oncol. – 2017. – 28 (4). – Рр. 119–142. [PubMed] [Google Scholar].

Kirson E.D. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors / E.D. Kirson, V. Dbaly, F. Tovarys, J. Vymazal, J.F. Soustiel, A. Itzhaki et al.// Proc. Natl. Acad. Sci. – USA. – 2007. – 104. – Рр. 10152–10157. [PMC free article] [PubMed] [Google Scholar].

Ronchetto F.Extremely low frequency‐modulated static magnetic fields to treat cancer: a pilot study on patients with advanced neoplasm to assess safety and acute toxicity / F. Ronchetto, D. Barone, M. Cintorino, M. Berardelli, S. Lissolo, R. Orlassino et al. // Bioelectromagnetics. – 2004. – 25. – Рр. 563-571. [PubMed] [Google Scholar].

Sabirov J.R., Ermatov N.J., Ruziev K.I. Middle radio waves for the treatment of oncological diseases at early stages (literature review) // Journal of Biomedicine and Practice. – Uzb. SpecialIssue-2. – 2020. – Рр. 698-710.